Stock BRNS BARINTHUS BIOTHERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq
Other stock markets
 03:28:02 2024-05-21 pm EDT 		5-day change 1st Jan Change
2.151 USD -10.33% Intraday chart for Barinthus Biotherapeutics plc -7.27% -41.70%
May. 13 Barinthus Biotherapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 01 Barinthus Biotherapeutics plc Appoints Leon Hooftman as Chief Medical Officer, Effective June 3, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BRNS Stock
  4. Revisions Barinthus Biotherapeutics plc
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW